Copyright ©The Author(s) 2016.
World J Diabetes. Sep 15, 2016; 7(17): 354-395
Published online Sep 15, 2016. doi: 10.4239/wjd.v7.i17.354
Figure 3
Figure 3 Therapeutic algorithm in patients with type 2 diabetes mellitus and chronic kidney disease. Adapted from Gómez-Huelgas et al[338]. aAvoid Glibenclamide. Use Gliclazide, Glipizide and Gliquidone. Use Glimepiride only if eGFR > 60 mL/min; bDose adjustment, except linagliptin; cMonitor fluid retention; dAdjust doses of exenatide and lixisenatide; eGenerally not use Metformin. Use only half the dose and monitor renal function; fNot recommended if eGFR < 60 mL/min. eGFR: Estimated glomerular filtration rate; HbA1c: Glycated haemoglobin; GLP-1: Glucagon-like peptide-1; SGLT2: Sodium-glucose co-transporter 2; DPP-4: Dypeptydil peptidase-4.